{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicjuxfynjnpjyx3cqfoew3r6ovothlqw242s7qs5s7wafz57sodvy",
    "uri": "at://did:plc:nzm6xlhdk3myu4xft63gxqp4/app.bsky.feed.post/3mhgmhccfjh72"
  },
  "path": "/health/higher-dose-wegovy-gets-us-nod-trials-show-over-20-average-weight-loss-says-drugmaker-11239975",
  "publishedAt": "2026-03-19T16:44:06.000Z",
  "site": "https://www.ndtv.com",
  "tags": [
    "Health"
  ],
  "textContent": "Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.",
  "title": "Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss"
}